Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is completed. It is testing escitalopram Augmentation for schizophrenia.
Location not clearly listedThis study is completed in China. It focuses on schizophrenia.
In BeijingThis study is completed in China. It is testing Levomilnacipran Hydrochloride Extended-Release Capsules for depression.
Multiple locations, including HefeiThis study was terminated in the United States and in Mexico. It is testing Low-Dose Ondansetron for OCD.
Multiple locations, including Beverly HillsThis study is completed in the United States, in Belgium, in Colombia, .... It is testing methylphenidate Hydrochloride Extended Release for ADHD.
Multiple locations, including Little Rock
This study was terminated in the United States. It is testing NeuroStar TMS Therapy for depression.
Multiple locations, including HartfordThis study was terminated in the United States and in Ukraine. It focuses on Bipolarity.
Multiple locations, including DothanThis study is completed in South Korea. It focuses on Schizophrenia.
In Jeonju
This study is completed in Italy. It focuses on schizophrenia.
In ItalyThis summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including BuffaloThis study exists to explore whether this type of care could improve care and understanding. Researchers are trying to understand whether this type of care can better support energy, concentration, and everyday functioning.
In CincinnatiThis study is ongoing in Germany. It focuses on schizophrenia.
In GermanyHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.